Publication

Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies

Lord, Philip
Spiering, Rachel
Aguillon, Juan C.
Anderson, Amy E.
Appel, Silke
Benitez-Ribas, Daniel
ten Brinke, Anja
Broere, Femke
Cools, Nathalie
Cuturi, María Cristina
... show 10 more
Citation
Lord P, Spiering R, Aguillon JC, Anderson AE, Appel S, Benitez-Ribas D, ten Brinke A, Broere F, Cools N, Cuturi MC, Diboll J, Geissler EK, Giannoukakis N, Gregori S, van Ham SM, Lattimer S, Marshall L, Harry RA, Hutchinson JA, Isaacs JD, Joosten I, van Kooten C, Lopez Diaz de Cerio A, Nikolic T, Oral HB, Sofronic-Milosavljevic L, Ritter T, Riquelme P, Thomson AW, Trucco M, Vives-Pi M, Martinez-Caceres EM, Hilkens CMU. (2016) Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies. PeerJ 4:e2300 https://doi.org/10.7717/peerj.2300
Abstract
Cellular therapies, with tolerogenic antigen-presenting cells (tolAPC) show great promise for the treatment of autoimmune diseases and for the prevention of destructive immune responses after transplantation The methodologies for generating tolAPC vary greatly between different laboratories, making it difficult to compare data from different studies; thus constituting a major hurdle for the development of standardised tolAPC therapeutic products. Here we describe an initiative by members of the tolAPC field to generate a minimum information model for tolAPC (MITAP), providing a reporting framework that will make differences and similarities between tolAPC products transparent. In this way, MITAP constitutes a first but important step towards the production of standardised and reproducible tolAPC for clinical application.
Funder
Publisher
PeerJ
Publisher DOI
10.7717/peerj.2300
Rights
Attribution-NonCommercial-NoDerivs 3.0 Ireland